NB-UVB phototherapy
Sponsors
Ruhr University of Bochum, University of Pennsylvania, Icahn School of Medicine at Mount Sinai, Assiut University, Hospital Universitario Dr. Jose E. Gonzalez
Conditions
Atopic DermatitisAtopic Dermatitis EczemaAutoimmuneAutoimmune Disease SkinAutoimmune DiseasesCardiovascular DiseasePsoriasisVitiligo
Phase 2
Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
CompletedNCT03123016
Start: 2017-04-14End: 2019-08-05Updated: 2019-08-28
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo
CompletedNCT05247489
Start: 2022-05-05End: 2023-12-19Updated: 2025-02-20
Phase 4
Unknown Phase
Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic Dermatitis
CompletedNCT00419406
Start: 2005-03-31End: 2007-12-31Updated: 2009-01-22
Psoriasis Microbiome and Phototherapy
CompletedNCT02552316
Start: 2014-12-31End: 2020-10-31Updated: 2020-12-02
Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma
NCT03155698
Start: 2021-08-31End: 2021-12-31Target: 50Updated: 2021-07-07
Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo
CompletedNCT04872257
Start: 2021-09-14End: 2022-11-01Updated: 2023-02-14
The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema)
Active, not recruitingNCT05704205
Start: 2023-02-22End: 2026-12-01Target: 316Updated: 2026-01-23
Autologous Nanofat Injection for Treatment of Stable Vitiligo
CompletedNCT07763262
Start: 2024-04-01End: 2026-03-01Updated: 2026-08-13